XML 175 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Jan. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Loss before Income Tax, Domestic and Foreign The Company’s net loss before income tax benefit / (expense) from income taxes includes the following components:
Year Ended January 31,
202320222021
Domestic$(139.5)$(212.6)$(171.4)
Foreign0.60.50.3
Net loss before income tax benefit / (expense)
$(138.9)$(212.1)$(171.1)
Schedule of Allocation of Income Tax
Total income taxes allocated to operations are as follows:

Year Ended January 31,
202320222021
Current provision:
Federal
$— $— $— 
State and local
Foreign
Total current provision
Deferred provision:
Federal
State and local
Foreign0.2 0.3 — 
Total deferred provision0.2 0.3 — 
Total income tax benefit / (expense)$0.2 $0.3 $— 
Schedule of Deferred Tax Assets (Liabilities)
The significant components of the Company’s net deferred tax assets (liabilities) are as follows:

Year Ended January 31,
20232022
Deferred tax assets:
Federal and state net operating loss carryforwards
$158.1 $149.7 
    Customer credit liabilities
1.9 1.9 
Interest limitation 50.0 40.5 
Capitalized R&D expenses10.1 — 
Tax credits5.7 4.2 
Share-based compensation 2.4 3.3 
Operating lease liabilities 11.8 14.4 
Other0.7 0.4 
Total deferred tax assets240.7 214.4 
Deferred tax liabilities:
Fixed assets(0.1)(4.2)
Operating lease right-of-use assets(7.6)(8.9)
Total deferred tax liabilities (7.7)(13.1)
Net deferred tax assets before valuation allowance233.0 201.3 
Less valuation allowance(232.4)(201.0)
Net deferred tax assets$0.6 $0.3 
Schedule of Effective Income Tax Rate Reconciliation The benefit for income taxes differs from the amount computed by applying the statutory U.S. Federal income tax rate to pretax loss because of the effect of the following items:
Year Ended January 31,
202320222021
Compute “expected” tax benefit21.00 %21.00 %21.00 %
State income taxes, net of federal benefit(0.01)%(0.01)%(0.01)%
Valuation of warrants— %(2.47)%— %
Nondeductible transaction costs— %(0.44)%— %
Nondeductible compensation(1.95)%(1.17)%— %
Share-based compensation(0.48)%(0.35)%(0.38)%
Current year change in valuation allowance (19.34)%(16.90)%(21.55)%
Other1.00 %0.48 %0.94 %
Income tax benefit (expense)0.22 %0.14 %— %
Schedule of Unrecognized Tax Benefits
The following table summarizes the unrecognized tax benefit activity for the periods indicated:

Year Ended January 31,
202320222021
Balance as of the beginning of the period $0.7 $0.6 $— 
Additions based on tax positions related to the current year 0.2 0.1 0.2 
Additions for tax positions of prior years— — 0.4 
Reductions for tax positions of prior years — — — 
Lapse of statute of limitations— — — 
Settlements— — — 
Balance as of the end of the period$0.9 $0.7 $0.6